Evaluation of VTP-50469, a menin-MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortium.
Saved in:
| Title: | Evaluation of VTP-50469, a menin-MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortium. |
|---|---|
| Authors: | Kurmasheva RT; UT Health San Antonio, Greehey Children's Cancer Research Institute, San Antonio, Texas., Bandyopadhyay A; UT Health San Antonio, Greehey Children's Cancer Research Institute, San Antonio, Texas., Favours E; UT Health San Antonio, Greehey Children's Cancer Research Institute, San Antonio, Texas., Pozo VD; UT Health San Antonio, Greehey Children's Cancer Research Institute, San Antonio, Texas., Ghilu S; UT Health San Antonio, Greehey Children's Cancer Research Institute, San Antonio, Texas., Phelps DA; UT Health San Antonio, Greehey Children's Cancer Research Institute, San Antonio, Texas., McGeehan GM; Syndax Pharmaceuticals, Waltham, Massachusetts., Erickson SW; Research Triangle Park, Research Triangle Institute, North Carolina., Smith MA; NCI, Cancer Therapy Evaluation Program, Bethesda, Maryland., Houghton PJ; UT Health San Antonio, Greehey Children's Cancer Research Institute, San Antonio, Texas. |
| Source: | Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Jul; Vol. 67 (7), pp. e28284. Date of Electronic Publication: 2020 Apr 25. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
